Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Medicinal Cannabis market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period.
This report presents the market size and development trends by detailing the Medicinal Cannabis market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Medicinal Cannabis market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Medicinal Cannabis industry and will help you to build a panoramic view of the industrial development.
Medicinal Cannabis Market, By Type:
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Medicinal Cannabis Market, By Application:
Pain
Arthritis
Neurological Disease
Others
Some of the leading players are as follows:
MGC Pharmaceuticals Limited
MGC Pharmaceuticals Ltd.
Insys Therapeutics, Inc.
Green Organic Dutchman
Medreleaf Corporation
Canntab Therapeutics Limited
Khiron life Sciences
Cronos Group
GW Pharmaceuticals, plc
Tilray
Medical Marijuana Inc.
BOL Pharma.
Canopy Growth Corporation
Chemesis International
Aphria, Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Medicinal Cannabis Market: Technology Type Analysis
-
4.1 Medicinal Cannabis Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Medicinal Cannabis Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Tetrahydrocannabinol (THC)
4.3.2 Cannabidiol (CBD)
5 Medicinal Cannabis Market: Product Analysis
-
5.1 Medicinal Cannabis Product Market Share Analysis, 2018 & 2026
-
5.2 Medicinal Cannabis Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Medicinal Cannabis Market: Application Analysis
-
6.1 Medicinal Cannabis Application Market Share Analysis, 2018 & 2026
-
6.2 Medicinal Cannabis Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pain
6.3.2 Arthritis
6.3.3 Neurological Disease
6.3.4 Others
7 Medicinal Cannabis Market: Regional Analysis
-
7.1 Medicinal Cannabis Regional Market Share Analysis, 2018 & 2026
-
7.2 Medicinal Cannabis Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 MGC Pharmaceuticals Limited
9.1.1 MGC Pharmaceuticals Limited Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 MGC Pharmaceuticals Ltd.
9.2.1 MGC Pharmaceuticals Ltd. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Insys Therapeutics, Inc.
9.3.1 Insys Therapeutics, Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Green Organic Dutchman
9.4.1 Green Organic Dutchman Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Medreleaf Corporation
9.5.1 Medreleaf Corporation Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Canntab Therapeutics Limited
9.6.1 Canntab Therapeutics Limited Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Khiron life Sciences
9.7.1 Khiron life Sciences Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Cronos Group
9.8.1 Cronos Group Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 GW Pharmaceuticals, plc
9.9.1 GW Pharmaceuticals, plc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Tilray
9.10.1 Tilray Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Medical Marijuana Inc.
9.11.1 Medical Marijuana Inc. Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 BOL Pharma.
9.12.1 BOL Pharma. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Canopy Growth Corporation
9.13.1 Canopy Growth Corporation Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Chemesis International
9.14.1 Chemesis International Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Aphria, Inc
9.15.1 Aphria, Inc Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
The List of Tables and Figures (Totals 72 Figures and 127 Tables)
Figure Tetrahydrocannabinol (THC) Medicinal Cannabis market, 2015 - 2026 (USD Million)
Figure Cannabidiol (CBD) Medicinal Cannabis market, 2015 - 2026 (USD Million)
Figure Pain market, 2015 - 2026 (USD Million)
Figure Arthritis market, 2015 - 2026 (USD Million)
Figure Neurological Disease market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Medicinal Cannabis market, by country, 2015 - 2026 (USD Million)
-
Table North America Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table North America Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table North America Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Canada Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Canada Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Europe Medicinal Cannabis market, by country, 2015 - 2026 (USD Million)
-
Table Europe Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Europe Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Europe Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Germany Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Germany Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table France Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table France Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Italy Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Italy Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Spain Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Spain Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Medicinal Cannabis market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table China Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table China Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Japan Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Japan Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table India Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table India Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Medicinal Cannabis market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table MEA Medicinal Cannabis market, by country, 2015 - 2026 (USD Million)
-
Table MEA Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table MEA Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table MEA Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Medicinal Cannabis market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Medicinal Cannabis market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Medicinal Cannabis market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table MGC Pharmaceuticals Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MGC Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Insys Therapeutics, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Green Organic Dutchman Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medreleaf Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Canntab Therapeutics Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Khiron life Sciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cronos Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GW Pharmaceuticals, plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tilray Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medical Marijuana Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BOL Pharma. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Canopy Growth Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chemesis International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aphria, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
